Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: Investigation in the QUASAR2 study, systematic review, and meta-analysis.
Rosmarin, D Palles, C Church, D Domingo, E Jones, A Johnstone, E Wang, H Love, S Julier, P Scudder, C
Rosmarin, D
Palles, C
Church, D
Domingo, E
Jones, A
Johnstone, E
Wang, H
Love, S
Julier, P
Scudder, C
Citations
Altmetric:
Abstract
Fluourouracil (FU) is a mainstay of chemotherapy, although toxicities are common. Genetic biomarkers have been used to predict these adverse events, but their utility is uncertain.
Authors
Rosmarin, D
Palles, C
Church, D
Domingo, E
Jones, A
Johnstone, E
Wang, H
Love, S
Julier, P
Scudder, C
Nicholson, G
Gonzalez-Neira, A
Martin, M
Sargent, D
Green, E
McLeod, H
Zanger, U
Schwab, M
Braun, Michael S
Seymour, M
Thompson, L
Lacas, B
Boige, V
Ribelles, N
Afzal, S
Enghusen, H
Astrup Jensen, S
Etienne-Grimaldi, M
Milano, G
Wadelius, M
Glimelius, B
Garmo, H
Gusella, M
Lecomte, T
Laurent-Puig, P
Martinez-Balibrea, E
Sharma, R
Garcia-Foncillas, J
Kleibl, Z
Morel, A
Pignon, J
Midgley, R
Kerr, D
Tomlinson, I
Palles, C
Church, D
Domingo, E
Jones, A
Johnstone, E
Wang, H
Love, S
Julier, P
Scudder, C
Nicholson, G
Gonzalez-Neira, A
Martin, M
Sargent, D
Green, E
McLeod, H
Zanger, U
Schwab, M
Braun, Michael S
Seymour, M
Thompson, L
Lacas, B
Boige, V
Ribelles, N
Afzal, S
Enghusen, H
Astrup Jensen, S
Etienne-Grimaldi, M
Milano, G
Wadelius, M
Glimelius, B
Garmo, H
Gusella, M
Lecomte, T
Laurent-Puig, P
Martinez-Balibrea, E
Sharma, R
Garcia-Foncillas, J
Kleibl, Z
Morel, A
Pignon, J
Midgley, R
Kerr, D
Tomlinson, I
Description
Date
2014-03-03
Publisher
Collections
Keywords
Type
Article
Citation
Genetic Markers of Toxicity From Capecitabine and Other Fluorouracil-Based Regimens: Investigation in the QUASAR2 Study, Systematic Review, and Meta-Analysis. 2014: J Clin Oncol